These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 36259856)
1. Anti-laminin 332 mucous membrane pemphigoid in a young woman treated with rituximab. Gitin A; Porta AD; Bisbee E; Braunlich K; Motaparthi K Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259856 [TBL] [Abstract][Full Text] [Related]
2. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid. Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077 [TBL] [Abstract][Full Text] [Related]
3. Anti-Laminin 332-Type Mucous Membrane Pemphigoid. Shi L; Li X; Qian H Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291670 [TBL] [Abstract][Full Text] [Related]
4. Disease Endotypes Predict the Severity of Mucous Membrane Pemphigoid. Fairley JA; Crowe TP; Fakhimi M; Palmer SJ; Greiner MA; Hellstein JW; Van Daele DJ; Messingham KN J Invest Dermatol; 2023 Aug; 143(8):1479-1486.e3. PubMed ID: 36870557 [TBL] [Abstract][Full Text] [Related]
5. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies. Chan LS; Yancey KB; Hammerberg C; Soong HK; Regezi JA; Johnson K; Cooper KD Arch Dermatol; 1993 Apr; 129(4):448-55. PubMed ID: 7682049 [TBL] [Abstract][Full Text] [Related]
6. A Chinese case of concurrent anti-laminin γ1 pemphigoid and anti-laminin 332-type mucous membrane pemphigoid. Liu W; Sun X; Gao Y; Li H; Shi L; Cheng L; Zhou Z; Li X; Qian H J Dermatol; 2023 Feb; 50(2):e69-e71. PubMed ID: 35811504 [No Abstract] [Full Text] [Related]
7. Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous Immunoglobulin. Tarnowietzki E; Peters T; Kraus L; Schmidt E; Scharffetter-Kochanek K Acta Derm Venereol; 2020 Oct; 100(17):adv00301. PubMed ID: 32852563 [No Abstract] [Full Text] [Related]
9. Mucous membrane pemphigoid. Du G; Patzelt S; van Beek N; Schmidt E Autoimmun Rev; 2022 Apr; 21(4):103036. PubMed ID: 34995762 [TBL] [Abstract][Full Text] [Related]
10. Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: A retrospective cohort study. Rashid H; Meijer JM; Bolling MC; Diercks GFH; Pas HH; Horváth B J Am Acad Dermatol; 2022 Jul; 87(1):48-55. PubMed ID: 34896128 [TBL] [Abstract][Full Text] [Related]
11. [Anti-laminin 332 mucous membrane pemphigoid with irreversible ocular and tracheobronchial involvement : Delayed diagnosis of a severe autoimmune bullous disease]. Syring FM; Zillikens D; Schmidt E; Kasperkiewicz M Hautarzt; 2019 May; 70(5):367-370. PubMed ID: 30963224 [TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype. Ahmed AR; Kalesinskas M; Kooper-Johnson S Autoimmun Rev; 2023 Oct; 22(10):103444. PubMed ID: 37673192 [TBL] [Abstract][Full Text] [Related]
13. Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid. Rashid H; Meijer JM; Bolling MC; Horváth B Br J Dermatol; 2022 Apr; 186(4):721-723. PubMed ID: 34747507 [No Abstract] [Full Text] [Related]
15. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared. Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D; Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569 [TBL] [Abstract][Full Text] [Related]
16. Use of rituximab in the treatment of mucous membrane pemphigoid: An analytic review. Farooq MM; Miloslavsky EM; Konikov N; Ahmed AR Autoimmun Rev; 2022 Aug; 21(8):103119. PubMed ID: 35688385 [TBL] [Abstract][Full Text] [Related]